Laura Wood on collaboration between departments when treating patients with cancer who are receiving immunotherapy treatments.
Laura Wood, RN, MSN, OCN, Cleveland Clinic explains the importance of a multidisciplinary approach when treating patients on immunotherapy.
Patients receiving immunotherapy treatments have autoimmune-type adverse events that are unlike those of chemotherapy. The side effects can be prolonged and require careful monitoring as well as multidisciplinary collaboration. Checking in with gastrointestinal, endocrinology, and other specialists can help to manage and monitor these side effects.
Oncology Financial Navigator Interventions Provide Benefits to Patients With Hematologic Cancers
March 30th 2023To evaluate the prevalence of financial toxicity and observe the effect of Coverage and Cost-of-Care Links, a program providing financial navigation, investigators initiated a nonrandomized study.
Arash Rezazadeh Kalebasty Discusses Darolutamide Combination Safety in the ARASENS Study
Lenvatinib Plus Pembrolizumab Elicits Durable Responses in Patients With Endometrial Cancer
Carolina Frailty Index Score May Be Applicable in Assessment of Patients with Ovarian Cancer
GCLQ and LELSQ Show Concordance in Assessment of Lymphedema in Patients With Endometrial Cancer
2 Clarke Drive
Cranbury, NJ 08512